The lancet. Diabetes & endocrinology

The most recent articles from: Lancet Diabetes Endocrinol June 2018

Lancet Diabetes Endocrinol · Jun 2018

Randomized Controlled Trial Multicenter Study

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.

Glucocorticoid-induced osteoporosis is the most common form of secondary osteoporosis and is associated with an estimated annual fracture rate of 5%. We aimed to assess the efficacy and safety of denosumab compared with risedronate in glucocorticoid-induced osteoporosis. ⋯ Amgen.

keep reading… or not…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,706,642 articles already indexed!